| Organism name | Crataegus spp. | 
|---|---|
| Genus | Crataegus | 
| Family | Rosaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Crataegus | 
|---|---|
| Linked NCBI taxonomy ID | 23159 | 
| Linked level | genus | 
| Family in NCBI taxonomy | Rosaceae | 
|---|---|
| ID | 3745 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | rosids | 
|---|---|
| ID | 71275 | 
| Species | Activity | 
|---|---|
| Crataegus spp. | Antiaggregant | 
| Crataegus spp. | Antianginal | 
| Crataegus spp. | Antiarrhythmic | 
| Crataegus spp. | Antiatherosclerotic | 
| Crataegus spp. | Anticapillary Fragility | 
| Crataegus spp. | Antiedemic | 
| Crataegus spp. | Antiinflammatory | 
| Crataegus spp. | Antioxidant | 
| Crataegus spp. | Antisclerotic | 
| Crataegus spp. | Antiseborrheic | 
| Crataegus spp. | Antithromboxane | 
| Crataegus spp. | Astringent | 
| Crataegus spp. | Bitter | 
| Crataegus spp. | cAMP-Phosphodiesterase Inhibitor | 
| Crataegus spp. | Cardioprotective | 
| Crataegus spp. | Cardiotonic | 
| Crataegus spp. | CNS Depressant | 
| Crataegus spp. | Collagen-Sparing | 
| Crataegus spp. | Coronary Vasodilator | 
| Crataegus spp. | Cyanogenetic | 
| Crataegus spp. | Depurative | 
| Crataegus spp. | Digestive | 
| Crataegus spp. | Diuretic | 
| Crataegus spp. | Fumitory | 
| Crataegus spp. | Hepatoprotective | 
| Crataegus spp. | Hypertensive | 
| Crataegus spp. | Hypocholesterolemic | 
| Crataegus spp. | Hypoglycemic | 
| Crataegus spp. | Hypotensive | 
| Crataegus spp. | Hypotriglyceridemic | 
| Crataegus spp. | Myocardioprotectant | 
| Crataegus spp. | Negative Bathmotropic | 
| Crataegus spp. | Negative Chronotropic | 
| Crataegus spp. | Nervine | 
| Crataegus spp. | Pancreaprotective | 
| Crataegus spp. | Phosphodiesterase Inhibitor | 
| Crataegus spp. | Positive Chronotropic | 
| Crataegus spp. | Positive Dromotropic | 
| Crataegus spp. | Positive Inotropic | 
| Crataegus spp. | Sedative | 
| Crataegus spp. | Stomachic | 
| Crataegus spp. | Tonic | 
| Crataegus spp. | Vasodilator | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00006203   | Orientin 2''-O-rhamnoside | No. 1 | No. 15 |   | ||||
| C00006208   | Isoorientin 2''-O-rhamnoside | CHEMBL1651280 | No. 1 | No. 15 |   | |||
| C00009075   | Procyanidin B1 / Epicatechin-(4beta->8)-catechin | CHEMBL38714 CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 | C479579 | 20 / 7 / 8 | No. 16 | No. 19 |   | |
| C00009077   | Procyanidin B2 / Epicathechin-(4beta->8)-epicathechin | CHEMBL38714 CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 | C479580 | 20 / 7 / 8 | 10 / 0 | No. 16 | No. 19 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00009075 C00009077 | 1 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00009075 C00009077 | 0 / 1 | 
| P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00009075 C00009077 | 0 / 0 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00009075 C00009077 | 0 / 0 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00009075 C00009077 | 3 / 3 | 
| P23467 | Receptor-type tyrosine-protein phosphatase beta | Receptor tyrosine-protein phosphatase | C00009075 C00009077 | 0 / 0 | 
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00009075 C00009077 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00009075 C00009077 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00009075 C00009077 | 0 / 1 | 
| Q05513 | Protein kinase C zeta type | Iota | C00009075 C00009077 | 0 / 0 | 
| Q04759 | Protein kinase C theta type | Delta | C00009075 C00009077 | 0 / 1 | 
| Q02156 | Protein kinase C epsilon type | Eta | C00009075 C00009077 | 0 / 0 | 
| O94806 | Serine/threonine-protein kinase D3 | Pkd | C00009075 C00009077 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00009075 C00009077 | 0 / 0 | 
| Q05655 | Protein kinase C delta type | Delta | C00009075 C00009077 | 0 / 0 | 
| P05129 | Protein kinase C gamma type | Alpha | C00009075 C00009077 | 1 / 1 | 
| P05771 | Protein kinase C beta type | Alpha | C00009075 C00009077 | 0 / 0 | 
| P24723 | Protein kinase C eta type | Eta | C00009075 C00009077 | 1 / 0 | 
| P41743 | Protein kinase C iota type | Iota | C00009075 C00009077 | 0 / 0 | 
| Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00009075 C00009077 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | C00009077 | 
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00009077 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00009077 | 
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | C00009077 | 
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic | C00009077 | 
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) | C00009077 | 
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) | C00009077 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00009077 | 
| 4240 | MFGE8, BA46, EDIL1, HMFG, HsT19888, MFG-E8, MFGM, OAcGD3S, SED1, SPAG10, hP47 | milk fat globule-EGF factor 8 protein | C00009077 | 
| 7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | C00009077 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #605361 | Spinocerebellar ataxia 14; sca14 | P05129 | 
| #601367 | Stroke, ischemic | P24723 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00063 | Spinocerebellar ataxia (SCA) | P05129
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00408 | Type I diabetes mellitus | Q04759
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) |